Overview
Bioactive T operates in life sciences, healthcare and nutrition, manufacturing prescription and over-the-counter medicines, hospital drugs and dietary supplements. Its European GMP-certified facilities support private-label, licensing and contract-manufacturing services.
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 56 days early.
- 202522/04/2026
- 202409/04/2025
- 202303/06/2024
- 202223/05/2023
- 202128/06/2022
- 202031/08/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Prescription medicines
- Over-the-counter medicines
- Dietary supplements
- Vitamins and minerals
- Capsules
- Tablets
- Creams
- Syrups
Website technology
- Website
- Next.js
Authorized Representatives
Manner of representation
The following are authorised to submit declarations of will and sign on behalf of the company: - in the case of a one-person management board – a member of the management board independently; - in the case of a multi-member management board – each member of the management board independently; - an independent commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Hussein Mahdi Mohammed Al-Bayatage 43 | 300 | $4,051.86 | 50% |
Osama Mahdi Mohammed Albayatage 39 | 300 | $4,051.86 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2018-01-15.
27 1240 6074 1787 0010 7762 1796- 63 1240 6074 1978 0010 7762 1783
- 72 1240 6074 1111 0010 7762 1709
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 134.6KPLN 134,577 |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $561$561 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $561$561 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Apr 28, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $105$105 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Nikalabsp. z o.o. | $3,148,345.23 | nikalab.pl | ||
| Bioticomsp. z o.o. | $2,901,963.26 | bioticom.pl | ||
| Efferta Blendssp. z o.o. | $3,020,056.75 | efferta.pl | ||
| Lab88sp. z o.o. | $1,707,981.35 | lab88.pl | ||
| Nutri Partnersp. z o.o. | $1,480,720.01 | nutri-partner.com | ||
| Auralab360sp. z o.o. | $1,385,659.31 | auralab360.pl | ||
| Methodo Polskasp. z o.o. | $1,337,205.31 | methodopolska.com | ||
| Bionatursp. z o.o. + limited partnership | $1,192,779.68 | bionatur.pl | ||
| Suplement.Iosp. z o.o. | $1,149,843.38 | suplement.io | ||
| Pharmavenesp. z o.o. | $783,187.61 | pharmavene.com |
Change history
| Date | Event | |
|---|---|---|
| 2019-12-30 | Address change (Ul. Fizylierów 20a, 04-497, Warszawa → Ul. Marii Rodziewiczówny 1/811, 04-187, Warszawa) | |
| 2017-11-30 | Entered in the register |
FAQ
Last updated: 2026-04-26